Clinical Nanomedicine

Applications of nanotechnology for treatment, diagnosis, monitoring, and control of biological systems has recently been referred to as “nanomedicine” by the National Institutes of Health. Research into the rational delivery and targeting of pharmaceutical, therapeutic, and diagnostic agents is at the forefront of projects in nanomedicine. These involve the identification of precise targets (cells and receptors) related to specific clinical conditions and choice of the appropriate nanocarriers to achieve the required responses while minimizing the side effects. Mononuclear phagocytes, dendritic cells, endothelial cells, and cancers (tumor cells, as well as tumor neovasculature) are key targets. Open Access journals make a quick review of articles and inform the authors within twenty one days of submission with the help of 3000 editorial team and quality review board which is ready to offer useful and informative results. Most of the peer-reviewed open access journals of OMICS Group is indexed in well-known indexing services like PubMed, Scopus, AGORA, ISI, ProQuest, Gale, Chemical Abstracts, and HINARI etc. Articles published in OMICS Group journals are permanently archived in the respective peer reviewed journals thus providing immediate and permanent access to individual papers and application of the scientific information. So, it is providing chance to get attract more number of students towards scientific research.

• Share this page
• 
• 
• 
• 
• 
• 

Last date updated on September, 2024